Senior Medical Director- Cell and Gene Therapy

Medical Strategy Lead, Cell And Gene Therapy

The IQVIA Cell And Gene Therapy Center Of Excellence (CAGT COE), a hub of CAGT clinical innovation, is growing! We are looking for an exceptional Board-Certified physician to join our team as a Medical Strategy Lead to help us expand our CAGT portfolio, with an emphasis on Gene Therapy/Gene Editing platforms, and advance this dynamic and rapidly expanding area of clinical development.

The CAGT Medical Strategy Lead is a subject matter expert with experience in clinical research and clinical trials in CAGT and especially in the areas of Gene Therapy/Gene Editing, who will be a champion for CAGT across IQVIA.

The key remit of the role is drive growth of the IQVIA CAGT portfolio through scientific and clinical expertise. The CAGT Medical Strategy Lead will be charged with using his/her clinical, scientific, and operational knowledge to harness the vast IQVIA data and clinical trial resources to develop innovative, data-driven, and patient-centered solutions for CAGT trials.

The CAGT Medical Strategy Lead will provide clinical and scientific expertise to all IQVIA divisions as requested and will collaborate closely with indication-specific teams to develop integrated strategies for CAGT clinical trials and studies.

The CAGT Medical Strategy Lead will also be responsible for early engagement business development activities, providing scientific knowledge and expertise to guide sponsors in CAGT development. As a subject matter expert in CAGT, the CAGT Medical Strategy Lead will drive thought leadership activities including presentations, publications, and interactions with the medical scientific community.

Responsibilities include:

• Accountable and responsible for creating innovative, evidence-based, and patient-centered delivery strategies and solutions for CAGT trials or studies, addressing the specific needs and challenges of each customer.
• In partnership with indication-specific Medical Strategy, Operations, Sales, and other functions, responsible for award of strategic and tactical new business to achieve annual Gross New Business targets.
• Responsible for the inclusion of CAGT elements into proposals.
• Provide scientific, clinical, and operational advice to internal stakeholders developing proposals.
• Support preparation of customer and bid defense meetings.
• Attends and presents at customer meeting, or bid defense or partnership meetings, as required.
• Participates in strategic business development activities including presentations to prospective clients and professional meetings.
• Maintains awareness of industry pipeline and scientific and business landscape.
• Leads CAGT thought leadership at IQVIA which may include publications, presentations, and taking a leadership role in scientific activities.

Qualifications include:

• A physician (MD or DO) or physician/scientist (MD/PhD) with experience in CAGT and especially in gene therapy/gene editing.
• A degree from an accredited and internationally recognized school is required.
• Certification in any medical sub-specialty will be considered and preference will be given to candidates with formal training in Neurology, Medical Genetics, or Cardiology.
• Highly qualified and experienced candidates with other terminal degrees such as a PhD or Pharm D will also be considered.
• At least 5 years clinical research relevant experience, including hands on operational delivery and/or drug development experience in gene therapy/gene editing.
• Robust and current knowledge of scientific, clinical, regulatory, commercial and competitive landscape in CAGT, especially in gene therapy/gene editing.
• Excellent skills in providing consultation and advice on multiple assignments are required, as well as initiative and flexibility.
• In depth knowledge of, and skill in applying, applicable clinical research regulatory requirements.
• Demonstrated ability to understand customer needs, have difficult conversations with internal/external stakeholders and customers, negotiate solutions and understand impacts on the overall offering.
• Strong clinical research skills and commitment to evidence-based and patient-centered clinical development.